Results 21 to 30 of about 15,470 (180)

Approach to a Child with Hypophosphatemia

Biomolecules
Hypophosphatemia is a rare ion disorder in children, but it carries the risk of serious clinical sequelae in tissues and organs with high energy requirements, such as bone tissue.
Agnieszka Antonowicz, Patryk Lipiński, Michał Popow, Piotr Skrzypczyk   +3 more
doaj   +1 more source

Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. [PDF]

PLoS ONE, 2011
Dysregulation of phosphate homeostasis as occurs in chronic kidney disease is associated with cardiovascular complications. It has been suggested that both hyperphosphatemia and hypophosphatemia can cause cardiovascular disease.
Ai Peng, Tianfu Wu, Caihong Zeng, Dinesh Rakheja, Jiankun Zhu, Ting Ye, Jack Hutcheson, Nosratola D Vaziri, Zhihong Liu, Chandra Mohan, Xin J Zhou   +10 more
doaj   +1 more source

Hypophosphatemia–factors associated with its development and 90-day mortality effect: a prospective observational study

Frontiers in Medicine
BackgroundSeveral factors are associated with hypophosphatemia. There is a paucity of data regarding the effects of restrictive energy delivery and phosphate renal handling with hypophosphatemia in the critically ill patient.MethodsThis is a single ...
Liran Statlender, Liran Statlender, Tzippy Shochat, Limor Rozilyo, Izhack Cherny, Jumana Amer, Guy Halperin, Eyal Robinson, Eyal Robinson, Moran Hellerman Itzhaki, Moran Hellerman Itzhaki, Moran Hellerman Itzhaki, Itai Bendavid, Itai Bendavid, Guy Fishman, Guy Fishman, Pierre Singer, Pierre Singer, Ilya Kagan, Ilya Kagan, Ilya Kagan   +20 more
doaj   +1 more source

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

Therapeutics and Clinical Risk Management, 2020
John A Glaspy,1 Michelle Z Lim-Watson,2 Michael A Libre,3 Swagata S Karkare,3 Nandini Hadker,3 Aleksandra Bajic-Lucas,2 William E Strauss,2 Naomi V Dahl2 1UCLA School of Medicine, Los Angeles, CA, USA; 2AMAG Pharmaceuticals, Inc., Waltham, MA, USA ...
Glaspy JA, Lim-Watson MZ, Libre MA, Karkare SS, Hadker N, Bajic-Lucas A, Strauss WE, Dahl NV   +7 more
doaj  

Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults

Renal Failure, 2019
Background: Hypophosphatemia is common during continuous renal replacement therapy (CRRT) in critically ill patients and can cause generalized muscle weakness, prolonged respiratory failure, and myocardial dysfunction. This study aimed to investigate the
Young-Hye Song, Eun-Hye Seo, Yang-Sook Yoo, Young-Il Jo   +3 more
doaj   +1 more source

Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report

Frontiers in Endocrinology, 2021
IntroductionRare FGF23-producing mesenchymal tumors lead to paraneoplastic tumor-induced osteomalacia (TIO) presenting with phosphate wasting, hypophosphatemia, chronic hypomineralization of the bone, fragility fractures and muscle weakness. Diagnosis of
Eeva M. Ryhänen, Camilla Schalin-Jäntti, Niina Matikainen   +2 more
doaj   +1 more source

Contributing factors to hypophosphatemia development in critically Ill ventilated patients: a retrospective cohort study

Scientific Reports
Hypophosphatemia (serum phosphate 
Liran Statlender, Orit Raphaeli, Tzippy Shochat, Eyal Robinson, Moran Hellerman Itzhaki, Itai Bendavid, Guy Fishman, Pierre Singer, Ilya Kagan   +8 more
doaj   +1 more source

Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study

BMJ Open Diabetes Research & Care, 2021
Introduction Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM) characterized by hyperglycemia and metabolic acidosis. Hypophosphatemia in DKA often occurs during hospital admittance for DKA.
Peter R van Dijk, Amarens van der Vaart, André P van Beek, Titia M Vriesendorp, B H R Wolffenbutel   +4 more
doaj   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

Hypophosphatemia

Archives of Internal Medicine, 1977
Hypophosphatemia, with or without phosphorus deficiency, is found commonly in patients with a variety of disease states. Severe hypophosphatemia is most often observed in chronic alcoholics, patients recovering from diabetic ketoacidosis and those being therapeutically re-fed after severe weight loss. Its consequences may be severe.
openaire   +5 more sources